Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase, Plasmid-Mediated Quinolone Resistance, and Carbapenemase-Producing Gram-Negative Bacilli in Burkina Faso.

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Soufiane SanouSylvain Godreuil

Abstract

The spreading of carbapenemase-producing gram-negative bacilli (GNB) must be considered as an "urgent" threat. The aim of this study was to determine the prevalence of extended spectrum β-lactamase (ESBL), plasmid-mediated quinolone resistance (PMQR), and carbapenemase-producing GNB and to characterize the supporting genes in GNB specimens isolated from patients and healthy volunteers in Burkina Faso. From April to June 2016, carbapenemase-producing GNB screening was performed in 1,230 consecutive clinical specimens, and 158 fecal samples from inpatients and healthy volunteers without digestive pathology at Souro Sanou University Hospital, Bobo Dioulasso. Strains were identified by matrix-assisted laser desorption ionization-time of flight and antimicrobial susceptibility was tested with the disk diffusion method on Müller-Hinton agar. The presence of carbapenemase, ESBL, and PMQR genes was assessed by multiplex PCR. The molecular epidemiological study was performed using multilocus sequence typing analysis. From the 1,230 clinical samples, 443 GNB strains were isolated among which 4 (0.9%) were carbapenemase-producing isolates (Escherichia coli, n = 1; Acinetobacter baumannii, n = 3). Among the 158 fecal samples tested for car...Continue Reading

References

May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Mar 1, 1981·Journal of Bacteriology·C I Kado, S T Liu
Jun 7, 2005·Journal of Microbiological Methods·Alessandra CarattoliE John Threlfall
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yohei Doi, Yoshichika Arakawa
Jul 17, 2007·Clinical Microbiology Reviews·Anne Marie Queenan, Karen Bush
Jan 15, 2010·The Journal of Antimicrobial Chemotherapy·Caroline DallenneGuillaume Arlet
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Laurent PoirelPatrice Nordmann
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Dec 6, 2011·International Journal of Antimicrobial Agents·Renu BharadwajYogesh Shouche
Apr 14, 2012·The Journal of Antimicrobial Chemotherapy·Laurent PoirelPatrice Nordmann
Apr 18, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R CantónUNKNOWN European Network on Carbapenemases
Apr 3, 2013·Cleveland Clinic Journal of Medicine·Federico Perez, David Van Duin
Nov 2, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Gunturu RevathiLi-Yueh Huang
Nov 10, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Xiaojuan WangHui Wang
Dec 18, 2013·International Journal of Medical Microbiology : IJMM·Fabrice CompainDominique Decré
Mar 13, 2014·The Australasian Medical Journal·Sumit RaiIqbal R Kaur
Apr 18, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·E RuppéS Matheron
Jul 30, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G BirgandJ C Lucet
Sep 28, 2014·The Journal of Antimicrobial Chemotherapy·Rendani I ManenzheMamadou Kaba
Jul 5, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Bei YaoJie Zhang
Jul 15, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·John Osei SekyereSabiha Essack
Feb 18, 2016·Antimicrobial Agents and Chemotherapy·Abdoul-Salam OuédraogoSylvain Godreuil
Dec 4, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·José Manuel Rodríguez-MartínezAlvaro Pascual
Nov 18, 2017·Annals of Clinical Microbiology and Antimicrobials·Kevin M RaibleSuresh G Joshi
Jun 5, 2018·International Journal of Antimicrobial Agents·Elizabeth A MitgangJesse L Goodman

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis

Software Mentioned

BLAST

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.